Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis

Abstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and health...

Full description

Bibliographic Details
Main Authors: J. M. Hatcher-Martin, J. L. McKay, A. F. Pybus, B. Sommerfeld, J. C. Howell, F. C. Goldstein, L. Wood, W. T. Hu, S. A. Factor
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-021-00247-x
_version_ 1797642655466782720
author J. M. Hatcher-Martin
J. L. McKay
A. F. Pybus
B. Sommerfeld
J. C. Howell
F. C. Goldstein
L. Wood
W. T. Hu
S. A. Factor
author_facet J. M. Hatcher-Martin
J. L. McKay
A. F. Pybus
B. Sommerfeld
J. C. Howell
F. C. Goldstein
L. Wood
W. T. Hu
S. A. Factor
author_sort J. M. Hatcher-Martin
collection DOAJ
description Abstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and healthy controls (HC, N = 12). Age and PD duration are not significantly different between groups. After adjusting for covariates and multiple comparisons, the anti-inflammatory marker, fractalkine, is significantly decreased in the PD groups compared to HC (P = 0.002), and further decreased in PD-FOG compared to PD-NoFOG (P = 0.007). The Alzheimer’s disease-related protein, Aβ42, is increased in PD-FOG compared to PD-NoFOG and HC (P = 0.001). Group differences obtained in individual biomarker analyses are confirmed with multivariate discriminant partial least squares regression (P < 0.001). High levels of Aβ42 in PD-FOG patients supports an increase over time from early to advanced state. Low levels of fractalkine might suggest anti-inflammatory effect. These findings warrant replication.
first_indexed 2024-03-11T14:03:26Z
format Article
id doaj.art-924d91281f934f699f164f0dae6b1608
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-11T14:03:26Z
publishDate 2021-11-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-924d91281f934f699f164f0dae6b16082023-11-02T03:32:10ZengNature Portfolionpj Parkinson's Disease2373-80572021-11-01711710.1038/s41531-021-00247-xCerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysisJ. M. Hatcher-Martin0J. L. McKay1A. F. Pybus2B. Sommerfeld3J. C. Howell4F. C. Goldstein5L. Wood6W. T. Hu7S. A. Factor8Jean & Paul Amos PD & Movement Disorders Program, Department of Neurology, Emory UniversityJean & Paul Amos PD & Movement Disorders Program, Department of Neurology, Emory UniversityDepartment of Mechanical Engineering, Georgia TechJean & Paul Amos PD & Movement Disorders Program, Department of Neurology, Emory UniversityNeurology Consultants of DallasNeuropsychology Program, Department of Neurology, Emory UniversityDepartment of Mechanical Engineering, Georgia TechAlzheimer’s Disease Research Center, Emory University and Cognitive Neurology Division, Rutgers-Robert Wood Johnson Medical School and Institute for Health, Health Care Policy, and Aging ResearchJean & Paul Amos PD & Movement Disorders Program, Department of Neurology, Emory UniversityAbstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and healthy controls (HC, N = 12). Age and PD duration are not significantly different between groups. After adjusting for covariates and multiple comparisons, the anti-inflammatory marker, fractalkine, is significantly decreased in the PD groups compared to HC (P = 0.002), and further decreased in PD-FOG compared to PD-NoFOG (P = 0.007). The Alzheimer’s disease-related protein, Aβ42, is increased in PD-FOG compared to PD-NoFOG and HC (P = 0.001). Group differences obtained in individual biomarker analyses are confirmed with multivariate discriminant partial least squares regression (P < 0.001). High levels of Aβ42 in PD-FOG patients supports an increase over time from early to advanced state. Low levels of fractalkine might suggest anti-inflammatory effect. These findings warrant replication.https://doi.org/10.1038/s41531-021-00247-x
spellingShingle J. M. Hatcher-Martin
J. L. McKay
A. F. Pybus
B. Sommerfeld
J. C. Howell
F. C. Goldstein
L. Wood
W. T. Hu
S. A. Factor
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
npj Parkinson's Disease
title Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
title_full Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
title_fullStr Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
title_full_unstemmed Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
title_short Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
title_sort cerebrospinal fluid biomarkers in parkinson s disease with freezing of gait an exploratory analysis
url https://doi.org/10.1038/s41531-021-00247-x
work_keys_str_mv AT jmhatchermartin cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT jlmckay cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT afpybus cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT bsommerfeld cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT jchowell cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT fcgoldstein cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT lwood cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT wthu cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis
AT safactor cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis